美国儿童头恶性瘤:20年的基于人口的研究
Simo Kraguljac1, Fouad Hajjar2, Richard Wong3
1University of Central Florida College of Medicine, Orlando, Florida, USA.
Pediatric blood & cancer
|November 24, 2024
概括
儿科头癌正在增加,女性的发病率更高,双模态年龄分布在非常小的儿童和晚青少年中达到顶峰. 这些趋势凸显了更新治疗策略的必要性.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 儿科 儿科 儿科
背景情况:
- 美国关于儿科头癌的最新流行病学数据有限.
- 需要更新趋势以告知未来的治疗策略.
研究的目的:
- 分析美国儿科HN癌症的当前流行病学趋势.
- 通过时间和年龄组来确定发病率的变化.
主要方法:
- 从2000年到2019年对监测流行病学和最终结果 (SEER) 数据库的分析.
- 包括0-21岁的患有HN恶性瘤的患者.
- 检查发病率和人口变化.
主要成果:
- 儿科HN瘤占所有儿科癌症的16.7%,平均年龄为13.1岁.
- 从2000-2004年到2015-2019年,总体发病率增加了28.5%,超过了儿童癌症的整体增长速度.
- 观察到一种双模式的发病率模式,在非常小的儿童 (<1岁) 和晚期青少年 (15-21岁) 中达到顶峰.
结论:
- 儿科HN瘤呈现双模年龄分布和日益增加的发病率趋势.
- 已注意到女性占主导地位,主要是由于甲状腺癌.
- 更新的数据和趋势分析对于推进儿科HN癌症的治疗方案至关重要.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


